These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22607799)

  • 1. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action.
    Kim JJ; Lee HM; Shin DM; Kim W; Yuk JM; Jin HS; Lee SH; Cha GH; Kim JM; Lee ZW; Shin SJ; Yoo H; Park YK; Park JB; Chung J; Yoshimori T; Jo EK
    Cell Host Microbe; 2012 May; 11(5):457-68. PubMed ID: 22607799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.
    Mohanty S; Jagannathan L; Ganguli G; Padhi A; Roy D; Alaridah N; Saha P; Nongthomba U; Godaly G; Gopal RK; Banerjee S; Sonawane A
    J Biol Chem; 2015 May; 290(21):13321-43. PubMed ID: 25825498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages.
    Dharra R; Radhakrishnan VS; Prasad T; Thakur Z; Cirillo JD; Sheoran A; Pandey AK; Kulharia M; Mehta PK
    Sci Rep; 2019 Jul; 9(1):10084. PubMed ID: 31300732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
    Matt U; Selchow P; Dal Molin M; Strommer S; Sharif O; Schilcher K; Andreoni F; Stenzinger A; Zinkernagel AS; Zeitlinger M; Sander P; Nemeth J
    Int J Antimicrob Agents; 2017 Jul; 50(1):55-62. PubMed ID: 28506804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment.
    Oh CT; Moon C; Choi TH; Kim BS; Jang J
    J Antimicrob Chemother; 2013 Mar; 68(3):601-9. PubMed ID: 23118147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
    Heifets L; Higgins M; Simon B
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway.
    Kim TS; Shin YH; Lee HM; Kim JK; Choe JH; Jang JC; Um S; Jin HS; Komatsu M; Cha GH; Chae HJ; Oh DC; Jo EK
    Sci Rep; 2017 Jun; 7(1):3431. PubMed ID: 28611371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
    Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
    Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
    Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
    Front Immunol; 2020; 11():36. PubMed ID: 32117228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lipid Virulence Factors of
    Bah A; Sanicas M; Nigou J; Guilhot C; Astarie-Dequeker C; Vergne I
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions.
    Kim TS; Jin YB; Kim YS; Kim S; Kim JK; Lee HM; Suh HW; Choe JH; Kim YJ; Koo BS; Kim HN; Jung M; Lee SH; Kim DK; Chung C; Son JW; Min JJ; Kim JM; Deng CX; Kim HS; Lee SR; Jo EK
    Autophagy; 2019 Aug; 15(8):1356-1375. PubMed ID: 30774023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.
    Boot M; Commandeur S; Subudhi AK; Bahira M; Smith TC; Abdallah AM; van Gemert M; Lelièvre J; Ballell L; Aldridge BB; Pain A; Speer A; Bitter W
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity.
    Choi SW; Gu Y; Peters RS; Salgame P; Ellner JJ; Timmins GS; Deretic V
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages.
    Gutierrez MG; Master SS; Singh SB; Taylor GA; Colombo MI; Deretic V
    Cell; 2004 Dec; 119(6):753-66. PubMed ID: 15607973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.